800 related articles for article (PubMed ID: 22085556)
21. Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.
Nizard M; Diniz MO; Roussel H; Tran T; Ferreira LC; Badoual C; Tartour E
Hum Vaccin Immunother; 2014; 10(8):2175-87. PubMed ID: 25424921
[TBL] [Abstract][Full Text] [Related]
22. [New routes of administration: epidermal, transcutaneous mucosal ways of vaccination].
Denis F; Alain S; Ploy MC
Med Sci (Paris); 2007 Apr; 23(4):379-85. PubMed ID: 17433227
[TBL] [Abstract][Full Text] [Related]
23. Stimulation of local antibody production: parenteral or mucosal vaccination?
Bouvet JP; Decroix N; Pamonsinlapatham P
Trends Immunol; 2002 Apr; 23(4):209-13. PubMed ID: 11923116
[TBL] [Abstract][Full Text] [Related]
24. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection.
Hong SH; Byun YH; Nguyen CT; Kim SY; Seong BL; Park S; Woo GJ; Yoon Y; Koh JT; Fujihashi K; Rhee JH; Lee SE
Vaccine; 2012 Jan; 30(2):466-74. PubMed ID: 22051136
[TBL] [Abstract][Full Text] [Related]
25. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.
Holmgren J; Adamsson J; Anjuère F; Clemens J; Czerkinsky C; Eriksson K; Flach CF; George-Chandy A; Harandi AM; Lebens M; Lehner T; Lindblad M; Nygren E; Raghavan S; Sanchez J; Stanford M; Sun JB; Svennerholm AM; Tengvall S
Immunol Lett; 2005 Mar; 97(2):181-8. PubMed ID: 15752556
[TBL] [Abstract][Full Text] [Related]
26. Mucosal immunization using recombinant plant-based oral vaccines.
Streatfield SJ
Methods; 2006 Feb; 38(2):150-7. PubMed ID: 16431131
[TBL] [Abstract][Full Text] [Related]
27. The potential of CpG oligodeoxynucleotides as mucosal adjuvants.
McCluskie MJ; Weeratna RD; Payette PJ; Davis HL
Crit Rev Immunol; 2001; 21(1-3):103-20. PubMed ID: 11642598
[TBL] [Abstract][Full Text] [Related]
28. "IDEAL" vaccines for resource poor settings.
Levine MM
Vaccine; 2011 Dec; 29 Suppl 4():D116-25. PubMed ID: 22486974
[TBL] [Abstract][Full Text] [Related]
29. Strategies for mucosal vaccine development.
Boyaka PN; Marinaro M; Vancott JL; Takahashi I; Fujihashi K; Yamamoto M; van Ginkel FW; Jackson RJ; Kiyono H; McGhee JR
Am J Trop Med Hyg; 1999 Apr; 60(4 Suppl):35-45. PubMed ID: 10344675
[TBL] [Abstract][Full Text] [Related]
30. Novel strategies using DNA for the induction of mucosal immunity.
McCluskie MJ; Davis HL
Crit Rev Immunol; 1999; 19(4):303-29. PubMed ID: 10530431
[TBL] [Abstract][Full Text] [Related]
31. Mucosal immunity: induction, dissemination, and effector functions.
Brandtzaeg P
Scand J Immunol; 2009 Dec; 70(6):505-15. PubMed ID: 19906191
[TBL] [Abstract][Full Text] [Related]
32. Bioadhesive delivery systems for mucosal vaccine delivery.
Baudner BC; O'Hagan DT
J Drug Target; 2010 Dec; 18(10):752-70. PubMed ID: 21039314
[TBL] [Abstract][Full Text] [Related]
33. Mucosal immunisation: Successful approaches to targeting different tissues.
Ferro VA; Carter KC
Methods; 2006 Feb; 38(2):61-4. PubMed ID: 16442812
[No Abstract] [Full Text] [Related]
34. [Nasal vaccines].
Kido H; Mizuno D; Takei T
Nihon Rinsho; 2008 Oct; 66(10):1881-7. PubMed ID: 18939485
[TBL] [Abstract][Full Text] [Related]
35. Mucosal vaccines: Strategies and challenges.
Li M; Wang Y; Sun Y; Cui H; Zhu SJ; Qiu HJ
Immunol Lett; 2020 Jan; 217():116-125. PubMed ID: 31669546
[TBL] [Abstract][Full Text] [Related]
36. Transgenic plant-based oral vaccines.
Lugade AA; Kalathil S; Heald JL; Thanavala Y
Immunol Invest; 2010; 39(4-5):468-82. PubMed ID: 20450287
[TBL] [Abstract][Full Text] [Related]
37. Modes of Action for Mucosal Vaccine Adjuvants.
Aoshi T
Viral Immunol; 2017; 30(6):463-470. PubMed ID: 28436755
[TBL] [Abstract][Full Text] [Related]
38. Mucosal vaccination and therapy with genetically modified lactic acid bacteria.
Wells J
Annu Rev Food Sci Technol; 2011; 2():423-45. PubMed ID: 22129390
[TBL] [Abstract][Full Text] [Related]
39. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.
Vajdy M; Srivastava I; Polo J; Donnelly J; O'Hagan D; Singh M
Immunol Cell Biol; 2004 Dec; 82(6):617-27. PubMed ID: 15550120
[TBL] [Abstract][Full Text] [Related]
40. Delivery strategies to enhance oral vaccination against enteric infections.
Davitt CJ; Lavelle EC
Adv Drug Deliv Rev; 2015 Aug; 91():52-69. PubMed ID: 25817337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
